Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 316 participants.
Also called NCT07028749
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 316 participants
- Sponsor
- Registry
-
NCT07028749
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Canada, New Zealand
- Registry status
- Recruiting
Technical summary
Registry record NCT07028749. Randomized; quadruple masking; primary purpose treatment. Start 2025-06-30 (actual); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
- Acronym
- TYDAL-TIMI 78
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- MAR001
- Intervention (Drug)
- Placebo
- Lead sponsor
- Marea Therapeutics
- Collaborator
- The TIMI Study Group
Record details
- Record id
cardio:ct-nct07028749- Content hash
55f9ca6f3baf63187c50e9c3199a16323d6b9bbf737f9414eae3239ec66b5974